This drug is approved for macular degeneration and is in testing for diabetic eye disease.
And it's timely -- we're seeing an epidemic of age-related macular degeneration with our aging population.
CNN: Smoking quadruples risk for vision-stealing eye disease
Dry macular degeneration is caused when drusen begin to accumulate in and around the macula.
CNN: New techniques slow progress of age-related vision loss
My father had macular degeneration for the last few years of his 83-year life.
FORBES: Avastin vs Lucentis: One Step Closer to Cost Rationing?
In 2007, the board restricted access to two drugs for macular degeneration, a cause of blindness.
They showed how high cholesterol levels could affect the immune system and lead to macular degeneration.
BBC: Macular degeneration: Cholesterol drugs 'may save sight'
This is an amazing result for macular degeneration, which has been, until now, irreversible.
However, studies have shown that supplements and a healthy diet can slow the progression of dry macular degeneration.
CNN: New techniques slow progress of age-related vision loss
It is now focused on seeking treatments for major eye diseases, including Wet AMD, or age-related macular degeneration.
FORBES: Teva Chairman Continues To Seek Undervalued Biopharmaceuticals
Lucentis is a prescription drug for the treatment of patients with wet age-related macular degeneration and macular edema.
Another group of patients who may find such technology useful, scientists say, is those with severe macular degeneration.
One was Visudyne (verteporfin), the first drug treatment for severe forms of macular degeneration, the leading cause of blindness.
Wilkinson: There are other data that have incriminated smoking in age-related macular degeneration.
CNN: Smoking quadruples risk for vision-stealing eye disease
One patient had macular degeneration, a very common but incurable eye disease, and the second had Stargardt disease.
"Absolutely, it is going to be a great target for the next generation of macular degeneration drugs, " says Zhang.
Genentech is testing a derivative of Avastin, rhuFab V2, in patients with macular degeneration, a leading cause of blindness.
The disease, macular degeneration, has become a modern scourge of an aging population.
The proteins were activated in mice bred to mimic the effects of age-related macular degeneration (AMD) and diabetic retinopathy.
The story everyone's writing is this: Genentech's being hurt by weakening sales of Lucentis, its drug for age-related macular degeneration.
When macular degeneration rendered her virtually blind, she used a magnifying glass to get through the Financial Times most days.
According to the National Eye Institute, about 85 to 90 percent of patients with advanced macular degeneration have the dry form.
CNN: New techniques slow progress of age-related vision loss
More importantly, Novartis will provide updates on its currently marketed and experimental drugs, including new medicines for cancer, hypertension and macular degeneration.
As of now, there is no FDA-approved treatment for dry macular degeneration, although a few drugs and devices are in clinical trials.
CNN: New techniques slow progress of age-related vision loss
There are two forms of age-related macular degeneration, or AMD: the dry form, known as non-neovascular, and the wet form, called neovascular.
CNN: New techniques slow progress of age-related vision loss
Two genes predict one's risk of getting the devastating eye disease macular degeneration--and your chances of going blind once you have it.
The cancer drug has never been rigorously tested in patients with macular degeneration, but in uncontrolled trials it appeared to work well.
That could represent further problems for Eyetech, which, along with Pfizer, already sells a treatment called Macugen for the disease--age-related macular degeneration (AMD).
Sirna already has a collaboration with Allergan for its lead compound, a drug to treat age-related macular degeneration, a leading cause of blindness.
Eyetech shares soared last year based on the success of Macugen, a treatment for age-related macular degeneration (AMD), a leading cause of blindness.
Today monoclonal antibodies are used to treat rheumatoid arthritis, transplant rejection, psoriasis, Crohn's disease, multiple sclerosis, macular degeneration and several types of cancer.
应用推荐